未登录

J

Jérôme Braudeau

CEA

H指数:12

被引数:1,017

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2024-05-013

OA

Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (vol 9, pg 480, 2022)

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2023-01-010

OA

Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2022-07-017

OAAI

Cerebral phospho-tau acts synergistically with soluble Aβ42 leading to Mild Cognitive Impairment in AAV-AD rats (Jan, 10.14283/jpad.2022.18, 2022)

JOURNAL OF NUTRITION HEALTH & AGING

IF4

2022-04-010

OA

Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE

IF7.8

2022-04-015

OAAI

Inhibition of DYRK1A proteolysis modifies its kinase specificity and rescues Alzheimer phenotype in APP/PS1 mice

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2019-03-1834

OAAI

Transient increase in sAPPα secretion in response to Aβ1-42 oligomers: an attempt of neuronal self-defense?

NEUROBIOLOGY OF AGING

IF3.5

2018-01-017

PREAI

Is it time to rethink the Alzheimer's disease drug development strategy by targeting its silent phase?

NEURAL REGENERATION RESEARCH

IF6.7

2018-01-014

OAAI

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice

Interleukin-2改善阿尔茨海默病小鼠的淀粉样蛋白病理，突触衰竭和记忆

IF11.7

2016-12-20149

OAAI

Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression

MOLECULAR NEURODEGENERATION

IF17.5

2016-01-1236

OAAI

Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model

Apps α 的病毒基因转移可挽救阿尔茨海默氏病小鼠模型中的突触衰竭

ACTA NEUROPATHOLOGICA

IF9.3

2015-11-04132

PREAI

Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology

HUMAN MOLECULAR GENETICS

IF3.2

2015-09-1096

OAAI

CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease

IF11.7

2015-07-02175

OAAI

A non convulsant alpha5 selective GABA-A inverse agonist restores cognitive deficits in a mouse model of Down syndrome

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2013-10-010

PREAI

PTD-XIAP protects against cerebral ischemia by anti-apoptotic and transcriptional regulatory mechanisms

NEUROBIOLOGY OF DISEASE

IF5.6

2006-04-0148

PREAI

Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

IF4.5

2004-11-0178

OAAI

The mechanisms of cell death in focal cerebral ischemia highlight neuroprotective perspectives by anti-caspase therapy

BIOCHEMICAL PHARMACOLOGY

IF5.6

2003-10-0127

PREAI